Island Pharmaceuticals Receives FDA feedback on clinical trial application
Island Pharmaceuticals (ILA) receives additional FDA feedback after its IND application for a phase two...
Island Pharmaceuticals Appoints Sofgen for one-off supply of ISLA-101
Island Pharmaceuticals (ILA) executes a one-off proposal with Sofgen for the manufacture of ISLA-101 for...